BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6326243)

  • 1. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
    Tally FP; Cuchural GJ; Malamy MH
    Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance and resistance transfer in anaerobic. A review.
    Tally FP; Malamy MH
    Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
    Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
    Betriu C; Cabronero C; Gomez M; Picazo JJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa.
    Koch CL; Derby P; Abratt VR
    J Antimicrob Chemother; 1998 Aug; 42(2):245-8. PubMed ID: 9738844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():63-71. PubMed ID: 3264832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.
    Cuchural GJ; Tally FP
    Drug Intell Clin Pharm; 1986; 20(7-8):567-73. PubMed ID: 3488895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.
    Pumbwe L; Wareham DW; Aduse-Opoku J; Brazier JS; Wexler HM
    Clin Microbiol Infect; 2007 Feb; 13(2):183-189. PubMed ID: 17328731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility patterns and resistance transferability among Bacteroides fragilis group isolates from patients with appendicitis in Bali, Indonesia.
    Suata K; Watanabe K; Ueno K; Homma M
    Clin Infect Dis; 1993 Apr; 16(4):561-6. PubMed ID: 8513066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaerobic bacteria in various infections and their antibiotic susceptibility patterns].
    Tunçkanat F; Günalp A
    Mikrobiyol Bul; 1986 Oct; 20(4):230-41. PubMed ID: 3657617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance factors in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1986; 49():56-63. PubMed ID: 3029859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial drugs used in the management of anaerobic infections in children.
    Brook I
    Drugs; 1983 Dec; 26(6):520-9. PubMed ID: 6360636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.